LeonaBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
LeonaBio, Inc. (LONA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.58 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 4.52M shares, a 2990.90% increase year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 61.38K shares, a 94.51% decline year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was -773.48K shares.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 490.49K shares, a 90.29% decline from fiscal 2024.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 5.05M shares, a 36.68% increase from fiscal 2023.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 3.70M shares, a 65.79% increase from fiscal 2022.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.23M shares, a 117.59% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.52M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 4.58M shares 10-Q · filed 2026-08-14 | 4.58M shares derived: sum of 3 quarters · filed 2026-08-14 | 3.81M shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 61.38K shares 10-Q · filed 2026-05-07 | 61.38K shares derived: sum of 2 quarters · filed 2026-05-07 | -712.10K shares derived: sum of 3 quarters · filed 2026-05-07 | -565.80K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -773.48K shares derived: sum of 2 quarters · filed 2026-03-31 | -627.18K shares derived: sum of 3 quarters · filed 2026-03-31 | 490.49K shares 10-K · filed 2026-03-31 |
| 2025-09-30 | -773.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -627.18K shares derived: sum of 2 quarters · filed 2025-11-06 | 490.49K shares 10-Q · filed 2025-11-06 | 1.45M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 146.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.26M shares 10-Q · filed 2025-08-07 | 2.23M shares derived: sum of 3 quarters · filed 2025-08-07 | 2.23M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 1.12M shares 10-Q · filed 2025-05-09 | 2.08M shares derived: sum of 2 quarters · filed 2025-05-09 | 2.08M shares derived: sum of 3 quarters · filed 2025-05-09 | 2.74M shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 964.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 964.07K shares derived: sum of 2 quarters · filed 2025-02-27 | 1.63M shares derived: sum of 3 quarters · filed 2025-02-27 | 5.05M shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 661.45K shares derived: sum of 2 quarters · filed 2024-11-07 | 4.09M shares 10-Q · filed 2024-11-07 | 4.09M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 661.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 4.09M shares 10-Q · filed 2024-08-01 | 4.09M shares derived: sum of 3 quarters · filed 2024-08-01 | 4.19M shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 3.43M shares 10-Q · filed 2024-05-15 | 3.43M shares derived: sum of 2 quarters · filed 2024-05-15 | 3.53M shares derived: sum of 3 quarters · filed 2024-05-15 | 4.41M shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 99.60K shares derived: sum of 2 quarters · filed 2024-02-22 | 981.79K shares derived: sum of 3 quarters · filed 2024-02-22 | 3.70M shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 99.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 981.79K shares derived: sum of 2 quarters · filed 2023-11-09 | 3.70M shares 10-Q · filed 2023-11-09 | 3.79M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 882.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 3.60M shares 10-Q · filed 2023-08-10 | 3.69M shares derived: sum of 3 quarters · filed 2023-08-10 | 3.84M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 2.71M shares 10-Q · filed 2023-05-11 | 2.80M shares derived: sum of 2 quarters · filed 2023-05-11 | 2.96M shares derived: sum of 3 quarters · filed 2023-05-11 | 3.43M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 88.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 244.00K shares derived: sum of 2 quarters · filed 2023-03-23 | 719.43K shares derived: sum of 3 quarters · filed 2023-03-23 | 2.23M shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 155.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 630.63K shares derived: sum of 2 quarters · filed 2022-11-10 | 2.14M shares 10-Q · filed 2022-11-10 | 2.51M shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 475.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.99M shares 10-Q · filed 2022-08-15 | 2.35M shares derived: sum of 3 quarters · filed 2022-08-15 | 2.35M shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 1.51M shares 10-Q · filed 2022-05-12 | 1.88M shares derived: sum of 2 quarters · filed 2022-05-12 | 1.88M shares derived: sum of 3 quarters · filed 2022-05-12 | 1.94M shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 366.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 366.00K shares derived: sum of 2 quarters · filed 2022-03-28 | 426.88K shares derived: sum of 3 quarters · filed 2022-03-28 | 1.02M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 60.88K shares derived: sum of 2 quarters · filed 2021-11-10 | 658.78K shares 10-Q · filed 2021-11-10 | 717.54K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 60.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 658.78K shares 10-Q · filed 2021-08-16 | 717.54K shares derived: sum of 3 quarters · filed 2021-08-16 | |
| 2021-03-31 | 597.89K shares 10-Q · filed 2021-05-13 | 656.65K shares derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2020-12-31 | 58.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 1.05M shares 10-K · filed 2021-03-25 | ||
| 2020-09-30 | 994.29K shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |